Smart Microneedle Patch Uses Hydrogen Gas to Heal Burns Without Scarring
Phase-Programmed Microneedles Enable Sequential Hydrogen and Quercetin Release for Scar-Reduced Regeneration of Burn Wounds
Research hubs: Oxidative Stress · Skin & Dermatology System
- Authors
- Yongnian Zeng, Zhigang Chu, Huiyuan Yang, Wen Zhang, Peng Jiang, Jiapeng Lei, Siyu Zhang, Qiongfang Ruan, Shuhua Liu, Wei Li
- Journal
- Advanced Science
- Year
- 2026
- DOI
- 10.1002/advs.78512
- Study Type
- Rabbit
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Burn Wounds
- Body System
- Integumentary
TL;DR
A microneedle patch that releases hydrogen and quercetin accelerated healing, reduced bacterial infections, and minimized scarring in animal models of burn wounds.
Key Finding
In mouse and rabbit burn models, microneedle patches delivering sequential hydrogen gas and quercetin reduced bacterial infection, lowered inflammation, and produced significantly less scarring with more normal skin architecture than controls.
Summary
This study tested a special bandage patch with tiny needles (microneedles) designed to treat infected burn wounds in mice and rabbits. The patch released hydrogen gas first to kill bacteria and reduce harmful oxidative stress (cell damage caused by unstable molecules), then slowly released a plant compound called quercetin to prevent excessive scarring. Researchers found the patch sped up wound healing, reduced infection, and produced skin with a more normal collagen (structural protein) structure compared to untreated wounds.
Practical Takeaway
This is early-stage animal research and does not involve hydrogen water — the hydrogen here was generated directly at a wound site using a chemical compound embedded in a specialized patch. The findings suggest hydrogen's antioxidant and antibacterial properties may support wound healing applications, but this technology is far from consumer use and no conclusions can be drawn for people drinking hydrogen water.
Abstract (excerpt)
Burn wounds complicated by bacterial infection and fibrotic scarring remain a major clinical challenge, demanding therapeutics capable of coordinated infection control, inflammation modulation, and tissue regeneration. Here, we report a phase-programmed microneedle (MN) patch (QR/AB-MNs) that…